Clinical Trial Update: Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the blood levels and fat-excretion effects of ATL-962 in obese subjects has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ATL-962

Snippet

Sponsor: Alizyme | Conditions: Obesity | Phase 1 | Status: COMPLETED